New Patch

Tweet

Created: 5/10/2007 6:47:42 AM Updated: 5/10/2007 6:48:03 AM WASHINGTON (AP) - Patients with early Parkinson's disease have a new treatment option - and it comes in the form of a patch. The once-daily Neuro patch is a first in American medical treatment for symptoms of the disease. It contains a drug called rotigotine, which federal regulators say has not been sold in the U-S before this. Parkinson's disease results from the loss of dopamine-producing brain cells. Rotigotine works by activating dopamine receptors, and mimicking the neurotransmitter's effect. The patch is made by Schwarz Pharma A-G. An estimated one million people in the U-S have Parkinson's, and an additional 60,000 cases are diagnosed each year Do you think this patch is safe? Do you think it is a move in the right direction? I was hoping stem cell would be on the front first in this area.